Brown-Forman Confirms It Is Part of Consortium Led by STZ to Acquire Allied Domecq
More News related to AED
- UBS Securities Upgrades AED to Buy
- STZ Led Consortium Will Not Pursue Allied Domecq Bid
- STZ Confirms Consortium's Preliminary Approach to Allied Domecq
- Brown-Forman Confirms It Is Part of Consortium Led by STZ to Acquire Allied Domecq
- AED Gets Preliminary Approach from STZ Led Consortium
More News related to BF.B
- David Moenning's Daily State of the Markets: 4/28
- Morning Movers 3/10: Citigroup (C) Up On Pandit Memo; AeroVironment (AVAV) Slammed On Guidance
- Brown-Forman (BF.B) Names Bareuther as Exec VP
- David Moenning's Daily State of the Markets: 12/05
- David Moenning's Daily State of the Markets: 8/28
More News related to STZ
- Constellation Considering Opportunities for Its Australian and U.K. Businesses
- Constellation Brands to Webcast Nov. 11 Institutional Investor Meeting from New York City
- Corona 'Can Do' With New 24-Ounce Cans
- Constellation (STZ) to Partner with Young's Distribution in Pac. Northwest
- Constellation Brands Announces Distribution Agreement With Young's Market Company
More News related to Mergers and Acquisitions
- Morgan Stanley Upgrades CHU to Overweight, Downgrades CHL, CHA to Equal Weight
- Goldman Sachs Upgraded Questar Corp. (STR) to Buy
- Avondale Securities Upgrades J.B. Hunt Transport (JBHT) to Outperform
- BMO Capital Upgrades Suncor Energy (SU) to Outperform
- MF Global Upgrades ArcelorMittal (MT) to Buy
UPDATE: Brown-Forman Corporation (NYSE: BF.b) confirmed today that it has joined a consortium led by Constellation Brands (NYSE: STZ) to consider a potential bid to acquire Allied Domecq (NYSE: AED). Other members of the consortium are Lion Capital (formerly Hicks Muse Europe) and Blackstone. Brown-Forman said there can be no assurances that an offer will be made by the consortium or that a transaction will result from this preliminary approach.
Related Categories
Mergers and AcquisitionsRumors
Stocks Mentioned
+0.48Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
